VivoSeq
Other

Screening

0

Pipeline Programs↗

7

Active Trials↗

2

Companies Involved↗

Screening is an early-stage landscape with 0 programs across 2 companies. The most active players are Avid Radiopharmaceuticals, GSK.

Intelligence

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

82/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Avid Radiopharmaceuticals

0 programs

PreclinicalGSK logo

GSK

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

28

clinical trials

Completed14 · 50%
Unknown status4 · 14%
Terminated3 · 11%
Not yet recruiting3 · 11%
Active, not recruiting2 · 7%
Recruiting2 · 7%

Clinical Trials

Trial Activity

28 trials

Effects of Salbutamol in Athletes and Implications for Screening and Sports
Recruiting·UUniversity of British Columbia·N/A·NCT07037511·64 enrolled
Characterization of a Functional Test for Mediterranean Family Fever Screening - 2
Recruiting·HHospices Civils de Lyon·N/A·NCT04478409·160 enrolled
Screening and Multiple Intervention on Lung Epidemics
Active, not recruiting·FFondazione IRCCS Istituto Nazionale dei Tumori, Milano·Phase 2·NCT03654105·2,000 enrolled
Breast Cancer Screening Decision Aid: A Survey-based Comparison of Video and Written Formats
Active, not recruiting·YYale University·Preclinical·NCT07515846·300 enrolled
Early Screening of Young COPD and Pre-COPD
Not yet recruiting·Yyanmengkang·N/A·NCT06844175·100 enrolled
Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions
Not yet recruiting·UUniversity of Massachusetts, Boston·Phase 2·NCT06876038·65 enrolled
Effectiveness and Mechanisms of a Precision Navigation Intervention to Improve Community Cancer Screening Participation: A Dual-Cohort Cluster Randomized Controlled Trial
Not yet recruiting·HHunan Cancer Hospital·Preclinical·NCT07676383·1,500 enrolled
T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients
Completed·AAssistance Publique - Hôpitaux de Paris·N/A·NCT02424474·933 enrolled
Rapid Screening Phenotype Test To Evaluate CYP 2C19 Enzyme Activity Using Stable Isotope [13C]Pantoprazole
Completed·IIndiana University·N/A·NCT00668902·25 enrolled
Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening
Completed·NNorgine·Phase 3·NCT00427089·360 enrolled
Screening for 3-D Visual Disorders in Preschool Children
Completed·AAssistance Publique - Hôpitaux de Paris·N/A·NCT05204069·95 enrolled
Targeted Screening for Taenia Solium Tapeworms
Completed·OOregon Health and Science University·N/A·NCT01296958·1,811 enrolled
Cessation Screening Project
Completed·UUniversity of Wisconsin, Madison·Phase 4·NCT04188873·529 enrolled
Screening Contrast-Enhanced Mammography as an Alternative to MRI
Completed·—·Phase 4·NCT04764292·601 enrolled
Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism.
Completed·—·N/A·NCT01950975·315 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)